nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—Tamoxifen—pancreatic cancer	0.0191	0.24	CbGbCtD
Sufentanil—Shivering—Gemcitabine—pancreatic cancer	0.0168	0.0474	CcSEcCtD
Sufentanil—CYP3A4—Erlotinib—pancreatic cancer	0.0162	0.204	CbGbCtD
Sufentanil—Miosis—Irinotecan—pancreatic cancer	0.0154	0.0434	CcSEcCtD
Sufentanil—CYP3A4—Irinotecan—pancreatic cancer	0.0147	0.185	CbGbCtD
Sufentanil—CYP3A4—Docetaxel—pancreatic cancer	0.0107	0.135	CbGbCtD
Sufentanil—CYP3A4—Sunitinib—pancreatic cancer	0.0107	0.135	CbGbCtD
Sufentanil—Urinary incontinence—Tamoxifen—pancreatic cancer	0.0088	0.0248	CcSEcCtD
Sufentanil—CYP3A4—Doxorubicin—pancreatic cancer	0.00801	0.101	CbGbCtD
Sufentanil—Euphoric mood—Fluorouracil—pancreatic cancer	0.00529	0.0149	CcSEcCtD
Sufentanil—Urinary tract disorder—Erlotinib—pancreatic cancer	0.00447	0.0126	CcSEcCtD
Sufentanil—Urethral disorder—Erlotinib—pancreatic cancer	0.00444	0.0125	CcSEcCtD
Sufentanil—Cardiac arrest—Irinotecan—pancreatic cancer	0.00444	0.0125	CcSEcCtD
Sufentanil—Cardiac arrest—Fluorouracil—pancreatic cancer	0.00425	0.012	CcSEcCtD
Sufentanil—Arrhythmia—Tamoxifen—pancreatic cancer	0.00409	0.0115	CcSEcCtD
Sufentanil—Chills—Erlotinib—pancreatic cancer	0.00406	0.0115	CcSEcCtD
Sufentanil—Arrhythmia—Erlotinib—pancreatic cancer	0.00404	0.0114	CcSEcCtD
Sufentanil—Bradycardia—Sunitinib—pancreatic cancer	0.00399	0.0113	CcSEcCtD
Sufentanil—Erythema—Tamoxifen—pancreatic cancer	0.00398	0.0112	CcSEcCtD
Sufentanil—Erythema—Erlotinib—pancreatic cancer	0.00394	0.0111	CcSEcCtD
Sufentanil—Urinary tract disorder—Sunitinib—pancreatic cancer	0.00387	0.0109	CcSEcCtD
Sufentanil—Bronchospasm—Gemcitabine—pancreatic cancer	0.00386	0.0109	CcSEcCtD
Sufentanil—Urethral disorder—Sunitinib—pancreatic cancer	0.00384	0.0108	CcSEcCtD
Sufentanil—Injection site pain—Epirubicin—pancreatic cancer	0.00367	0.0104	CcSEcCtD
Sufentanil—Chills—Sunitinib—pancreatic cancer	0.00352	0.00992	CcSEcCtD
Sufentanil—Arrhythmia—Sunitinib—pancreatic cancer	0.0035	0.00987	CcSEcCtD
Sufentanil—Hypertension—Tamoxifen—pancreatic cancer	0.00344	0.0097	CcSEcCtD
Sufentanil—Erythema—Sunitinib—pancreatic cancer	0.00341	0.00962	CcSEcCtD
Sufentanil—Injection site pain—Doxorubicin—pancreatic cancer	0.0034	0.00958	CcSEcCtD
Sufentanil—Bradycardia—Irinotecan—pancreatic cancer	0.00329	0.00927	CcSEcCtD
Sufentanil—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.0031	0.00876	CcSEcCtD
Sufentanil—Urethral disorder—Gemcitabine—pancreatic cancer	0.00308	0.00869	CcSEcCtD
Sufentanil—Hypertension—Sunitinib—pancreatic cancer	0.00294	0.00831	CcSEcCtD
Sufentanil—Chills—Irinotecan—pancreatic cancer	0.0029	0.00817	CcSEcCtD
Sufentanil—Arrhythmia—Irinotecan—pancreatic cancer	0.00288	0.00813	CcSEcCtD
Sufentanil—Chills—Gemcitabine—pancreatic cancer	0.00282	0.00796	CcSEcCtD
Sufentanil—Arrhythmia—Gemcitabine—pancreatic cancer	0.00281	0.00792	CcSEcCtD
Sufentanil—Arrhythmia—Fluorouracil—pancreatic cancer	0.00276	0.00779	CcSEcCtD
Sufentanil—Bronchospasm—Docetaxel—pancreatic cancer	0.00274	0.00773	CcSEcCtD
Sufentanil—Erythema—Gemcitabine—pancreatic cancer	0.00274	0.00772	CcSEcCtD
Sufentanil—Erythema—Fluorouracil—pancreatic cancer	0.00269	0.00759	CcSEcCtD
Sufentanil—Body temperature increased—Erlotinib—pancreatic cancer	0.00254	0.00717	CcSEcCtD
Sufentanil—Hypertension—Irinotecan—pancreatic cancer	0.00243	0.00684	CcSEcCtD
Sufentanil—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00239	0.00675	CcSEcCtD
Sufentanil—Hypertension—Gemcitabine—pancreatic cancer	0.00236	0.00667	CcSEcCtD
Sufentanil—Confusional state—Irinotecan—pancreatic cancer	0.00231	0.00652	CcSEcCtD
Sufentanil—Pruritus—Tamoxifen—pancreatic cancer	0.0023	0.00649	CcSEcCtD
Sufentanil—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00229	0.00647	CcSEcCtD
Sufentanil—Pruritus—Erlotinib—pancreatic cancer	0.00227	0.00642	CcSEcCtD
Sufentanil—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00223	0.0063	CcSEcCtD
Sufentanil—Confusional state—Fluorouracil—pancreatic cancer	0.00221	0.00625	CcSEcCtD
Sufentanil—Urinary tract disorder—Docetaxel—pancreatic cancer	0.0022	0.00622	CcSEcCtD
Sufentanil—Body temperature increased—Sunitinib—pancreatic cancer	0.0022	0.00621	CcSEcCtD
Sufentanil—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.0022	0.0062	CcSEcCtD
Sufentanil—Urethral disorder—Docetaxel—pancreatic cancer	0.00219	0.00617	CcSEcCtD
Sufentanil—Dizziness—Tamoxifen—pancreatic cancer	0.00215	0.00606	CcSEcCtD
Sufentanil—Tachycardia—Fluorouracil—pancreatic cancer	0.00214	0.00605	CcSEcCtD
Sufentanil—Hypotension—Irinotecan—pancreatic cancer	0.00214	0.00604	CcSEcCtD
Sufentanil—Dizziness—Erlotinib—pancreatic cancer	0.00213	0.006	CcSEcCtD
Sufentanil—Hypotension—Gemcitabine—pancreatic cancer	0.00209	0.00589	CcSEcCtD
Sufentanil—Cardiac arrest—Epirubicin—pancreatic cancer	0.00207	0.00583	CcSEcCtD
Sufentanil—Vomiting—Tamoxifen—pancreatic cancer	0.00207	0.00583	CcSEcCtD
Sufentanil—Hypotension—Fluorouracil—pancreatic cancer	0.00205	0.00579	CcSEcCtD
Sufentanil—Hypersensitivity—Sunitinib—pancreatic cancer	0.00205	0.00579	CcSEcCtD
Sufentanil—Rash—Tamoxifen—pancreatic cancer	0.00205	0.00578	CcSEcCtD
Sufentanil—Dermatitis—Tamoxifen—pancreatic cancer	0.00205	0.00578	CcSEcCtD
Sufentanil—Vomiting—Erlotinib—pancreatic cancer	0.00204	0.00577	CcSEcCtD
Sufentanil—Somnolence—Irinotecan—pancreatic cancer	0.00204	0.00575	CcSEcCtD
Sufentanil—Headache—Tamoxifen—pancreatic cancer	0.00204	0.00574	CcSEcCtD
Sufentanil—Rash—Erlotinib—pancreatic cancer	0.00203	0.00572	CcSEcCtD
Sufentanil—Dermatitis—Erlotinib—pancreatic cancer	0.00203	0.00571	CcSEcCtD
Sufentanil—Headache—Erlotinib—pancreatic cancer	0.00201	0.00568	CcSEcCtD
Sufentanil—Chills—Docetaxel—pancreatic cancer	0.002	0.00565	CcSEcCtD
Sufentanil—Arrhythmia—Docetaxel—pancreatic cancer	0.00199	0.00562	CcSEcCtD
Sufentanil—Somnolence—Gemcitabine—pancreatic cancer	0.00199	0.0056	CcSEcCtD
Sufentanil—Pruritus—Sunitinib—pancreatic cancer	0.00197	0.00556	CcSEcCtD
Sufentanil—Somnolence—Fluorouracil—pancreatic cancer	0.00195	0.00551	CcSEcCtD
Sufentanil—Erythema—Docetaxel—pancreatic cancer	0.00194	0.00548	CcSEcCtD
Sufentanil—Nausea—Tamoxifen—pancreatic cancer	0.00193	0.00545	CcSEcCtD
Sufentanil—Cardiac arrest—Doxorubicin—pancreatic cancer	0.00191	0.0054	CcSEcCtD
Sufentanil—Nausea—Erlotinib—pancreatic cancer	0.00191	0.00539	CcSEcCtD
Sufentanil—Feeling abnormal—Irinotecan—pancreatic cancer	0.00189	0.00533	CcSEcCtD
Sufentanil—Dizziness—Sunitinib—pancreatic cancer	0.00184	0.00519	CcSEcCtD
Sufentanil—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00184	0.00519	CcSEcCtD
Sufentanil—Body temperature increased—Irinotecan—pancreatic cancer	0.00181	0.00511	CcSEcCtD
Sufentanil—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00181	0.00511	CcSEcCtD
Sufentanil—Vomiting—Sunitinib—pancreatic cancer	0.00177	0.00499	CcSEcCtD
Sufentanil—Body temperature increased—Gemcitabine—pancreatic cancer	0.00177	0.00498	CcSEcCtD
Sufentanil—Rash—Sunitinib—pancreatic cancer	0.00176	0.00495	CcSEcCtD
Sufentanil—Dermatitis—Sunitinib—pancreatic cancer	0.00175	0.00495	CcSEcCtD
Sufentanil—Headache—Sunitinib—pancreatic cancer	0.00174	0.00492	CcSEcCtD
Sufentanil—Body temperature increased—Fluorouracil—pancreatic cancer	0.00174	0.0049	CcSEcCtD
Sufentanil—Hypersensitivity—Irinotecan—pancreatic cancer	0.00169	0.00477	CcSEcCtD
Sufentanil—Hypertension—Docetaxel—pancreatic cancer	0.00168	0.00473	CcSEcCtD
Sufentanil—Nausea—Sunitinib—pancreatic cancer	0.00165	0.00466	CcSEcCtD
Sufentanil—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00162	0.00456	CcSEcCtD
Sufentanil—Confusional state—Docetaxel—pancreatic cancer	0.0016	0.00451	CcSEcCtD
Sufentanil—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00158	0.00447	CcSEcCtD
Sufentanil—Pruritus—Gemcitabine—pancreatic cancer	0.00158	0.00446	CcSEcCtD
Sufentanil—Pruritus—Fluorouracil—pancreatic cancer	0.00155	0.00438	CcSEcCtD
Sufentanil—Tachycardia—Docetaxel—pancreatic cancer	0.00155	0.00436	CcSEcCtD
Sufentanil—Bradycardia—Epirubicin—pancreatic cancer	0.00153	0.00432	CcSEcCtD
Sufentanil—Dizziness—Irinotecan—pancreatic cancer	0.00152	0.00428	CcSEcCtD
Sufentanil—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00149	0.00419	CcSEcCtD
Sufentanil—Hypotension—Docetaxel—pancreatic cancer	0.00148	0.00418	CcSEcCtD
Sufentanil—Urethral disorder—Epirubicin—pancreatic cancer	0.00148	0.00416	CcSEcCtD
Sufentanil—Vomiting—Irinotecan—pancreatic cancer	0.00146	0.00411	CcSEcCtD
Sufentanil—Dizziness—Fluorouracil—pancreatic cancer	0.00145	0.0041	CcSEcCtD
Sufentanil—Rash—Irinotecan—pancreatic cancer	0.00145	0.00408	CcSEcCtD
Sufentanil—Dermatitis—Irinotecan—pancreatic cancer	0.00144	0.00407	CcSEcCtD
Sufentanil—Headache—Irinotecan—pancreatic cancer	0.00144	0.00405	CcSEcCtD
Sufentanil—Vomiting—Gemcitabine—pancreatic cancer	0.00142	0.00401	CcSEcCtD
Sufentanil—Bradycardia—Doxorubicin—pancreatic cancer	0.00142	0.004	CcSEcCtD
Sufentanil—Somnolence—Docetaxel—pancreatic cancer	0.00141	0.00398	CcSEcCtD
Sufentanil—Rash—Gemcitabine—pancreatic cancer	0.00141	0.00397	CcSEcCtD
Sufentanil—Dermatitis—Gemcitabine—pancreatic cancer	0.00141	0.00397	CcSEcCtD
Sufentanil—Headache—Gemcitabine—pancreatic cancer	0.0014	0.00395	CcSEcCtD
Sufentanil—Vomiting—Fluorouracil—pancreatic cancer	0.0014	0.00394	CcSEcCtD
Sufentanil—Rash—Fluorouracil—pancreatic cancer	0.00138	0.00391	CcSEcCtD
Sufentanil—Dermatitis—Fluorouracil—pancreatic cancer	0.00138	0.0039	CcSEcCtD
Sufentanil—Headache—Fluorouracil—pancreatic cancer	0.00138	0.00388	CcSEcCtD
Sufentanil—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00137	0.00388	CcSEcCtD
Sufentanil—Urethral disorder—Doxorubicin—pancreatic cancer	0.00136	0.00385	CcSEcCtD
Sufentanil—Nausea—Irinotecan—pancreatic cancer	0.00136	0.00384	CcSEcCtD
Sufentanil—Chills—Epirubicin—pancreatic cancer	0.00135	0.00381	CcSEcCtD
Sufentanil—Arrhythmia—Epirubicin—pancreatic cancer	0.00134	0.00379	CcSEcCtD
Sufentanil—Nausea—Gemcitabine—pancreatic cancer	0.00133	0.00374	CcSEcCtD
Sufentanil—Erythema—Epirubicin—pancreatic cancer	0.00131	0.0037	CcSEcCtD
Sufentanil—Feeling abnormal—Docetaxel—pancreatic cancer	0.00131	0.00368	CcSEcCtD
Sufentanil—Nausea—Fluorouracil—pancreatic cancer	0.0013	0.00368	CcSEcCtD
Sufentanil—Body temperature increased—Docetaxel—pancreatic cancer	0.00125	0.00353	CcSEcCtD
Sufentanil—Chills—Doxorubicin—pancreatic cancer	0.00125	0.00352	CcSEcCtD
Sufentanil—Arrhythmia—Doxorubicin—pancreatic cancer	0.00124	0.00351	CcSEcCtD
Sufentanil—Erythema—Doxorubicin—pancreatic cancer	0.00121	0.00342	CcSEcCtD
Sufentanil—Hypersensitivity—Docetaxel—pancreatic cancer	0.00117	0.00329	CcSEcCtD
Sufentanil—Hypertension—Epirubicin—pancreatic cancer	0.00113	0.00319	CcSEcCtD
Sufentanil—Pruritus—Docetaxel—pancreatic cancer	0.00112	0.00316	CcSEcCtD
Sufentanil—Confusional state—Epirubicin—pancreatic cancer	0.00108	0.00304	CcSEcCtD
Sufentanil—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00107	0.00302	CcSEcCtD
Sufentanil—Dizziness—Docetaxel—pancreatic cancer	0.00105	0.00296	CcSEcCtD
Sufentanil—Hypertension—Doxorubicin—pancreatic cancer	0.00105	0.00295	CcSEcCtD
Sufentanil—Tachycardia—Epirubicin—pancreatic cancer	0.00104	0.00294	CcSEcCtD
Sufentanil—Vomiting—Docetaxel—pancreatic cancer	0.00101	0.00284	CcSEcCtD
Sufentanil—Rash—Docetaxel—pancreatic cancer	0.000999	0.00282	CcSEcCtD
Sufentanil—Hypotension—Epirubicin—pancreatic cancer	0.000999	0.00282	CcSEcCtD
Sufentanil—Dermatitis—Docetaxel—pancreatic cancer	0.000998	0.00282	CcSEcCtD
Sufentanil—Confusional state—Doxorubicin—pancreatic cancer	0.000997	0.00281	CcSEcCtD
Sufentanil—Headache—Docetaxel—pancreatic cancer	0.000993	0.0028	CcSEcCtD
Sufentanil—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000989	0.00279	CcSEcCtD
Sufentanil—Tachycardia—Doxorubicin—pancreatic cancer	0.000965	0.00272	CcSEcCtD
Sufentanil—Somnolence—Epirubicin—pancreatic cancer	0.00095	0.00268	CcSEcCtD
Sufentanil—Nausea—Docetaxel—pancreatic cancer	0.000941	0.00266	CcSEcCtD
Sufentanil—Hypotension—Doxorubicin—pancreatic cancer	0.000924	0.00261	CcSEcCtD
Sufentanil—Feeling abnormal—Epirubicin—pancreatic cancer	0.000881	0.00249	CcSEcCtD
Sufentanil—Somnolence—Doxorubicin—pancreatic cancer	0.000879	0.00248	CcSEcCtD
Sufentanil—Body temperature increased—Epirubicin—pancreatic cancer	0.000845	0.00238	CcSEcCtD
Sufentanil—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000815	0.0023	CcSEcCtD
Sufentanil—Hypersensitivity—Epirubicin—pancreatic cancer	0.000788	0.00222	CcSEcCtD
Sufentanil—Body temperature increased—Doxorubicin—pancreatic cancer	0.000782	0.00221	CcSEcCtD
Sufentanil—Pruritus—Epirubicin—pancreatic cancer	0.000756	0.00213	CcSEcCtD
Sufentanil—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000729	0.00206	CcSEcCtD
Sufentanil—Dizziness—Epirubicin—pancreatic cancer	0.000707	0.00199	CcSEcCtD
Sufentanil—Pruritus—Doxorubicin—pancreatic cancer	0.0007	0.00197	CcSEcCtD
Sufentanil—Vomiting—Epirubicin—pancreatic cancer	0.00068	0.00192	CcSEcCtD
Sufentanil—Rash—Epirubicin—pancreatic cancer	0.000674	0.0019	CcSEcCtD
Sufentanil—Dermatitis—Epirubicin—pancreatic cancer	0.000673	0.0019	CcSEcCtD
Sufentanil—Headache—Epirubicin—pancreatic cancer	0.00067	0.00189	CcSEcCtD
Sufentanil—Dizziness—Doxorubicin—pancreatic cancer	0.000654	0.00185	CcSEcCtD
Sufentanil—Nausea—Epirubicin—pancreatic cancer	0.000635	0.00179	CcSEcCtD
Sufentanil—Vomiting—Doxorubicin—pancreatic cancer	0.000629	0.00177	CcSEcCtD
Sufentanil—Rash—Doxorubicin—pancreatic cancer	0.000624	0.00176	CcSEcCtD
Sufentanil—Dermatitis—Doxorubicin—pancreatic cancer	0.000623	0.00176	CcSEcCtD
Sufentanil—Headache—Doxorubicin—pancreatic cancer	0.00062	0.00175	CcSEcCtD
Sufentanil—Nausea—Doxorubicin—pancreatic cancer	0.000588	0.00166	CcSEcCtD
Sufentanil—OPRD1—Signaling Pathways—HEY1—pancreatic cancer	0.000406	0.000718	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—SST—pancreatic cancer	0.000406	0.000717	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000403	0.000712	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000403	0.000712	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CNR1—pancreatic cancer	0.000402	0.000711	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.0004	0.000706	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NRP1—pancreatic cancer	0.0004	0.000706	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SSTR1—pancreatic cancer	0.000397	0.000702	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PPY—pancreatic cancer	0.00039	0.000688	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—GCG—pancreatic cancer	0.000389	0.000687	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCK—pancreatic cancer	0.000388	0.000685	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HEY2—pancreatic cancer	0.000385	0.00068	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SSTR2—pancreatic cancer	0.000383	0.000676	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CNR2—pancreatic cancer	0.000378	0.000667	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GLP1R—pancreatic cancer	0.000378	0.000667	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000378	0.000667	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GAST—pancreatic cancer	0.000376	0.000664	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000375	0.000662	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCKAR—pancreatic cancer	0.000372	0.000657	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000371	0.000655	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCKBR—pancreatic cancer	0.000369	0.000653	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—SST—pancreatic cancer	0.000369	0.000651	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000367	0.000649	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—GCG—pancreatic cancer	0.000362	0.000639	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—JAG2—pancreatic cancer	0.00036	0.000637	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HEY1—pancreatic cancer	0.000356	0.000629	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SCT—pancreatic cancer	0.000356	0.000629	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MEN1—pancreatic cancer	0.000355	0.000627	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DTX4—pancreatic cancer	0.000347	0.000614	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GLI1—pancreatic cancer	0.000347	0.000614	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000345	0.00061	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CNR1—pancreatic cancer	0.00034	0.000601	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCK—pancreatic cancer	0.00034	0.000601	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SHH—pancreatic cancer	0.000339	0.000599	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000338	0.000597	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NRP1—pancreatic cancer	0.000338	0.000597	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000337	0.000595	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IAPP—pancreatic cancer	0.000335	0.000591	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GLP1R—pancreatic cancer	0.000331	0.000585	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CNR2—pancreatic cancer	0.000331	0.000585	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000331	0.000585	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—GCG—pancreatic cancer	0.000329	0.00058	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCKAR—pancreatic cancer	0.000326	0.000576	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HEY2—pancreatic cancer	0.000325	0.000575	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTHLH—pancreatic cancer	0.000321	0.000567	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTCH1—pancreatic cancer	0.000321	0.000567	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GAST—pancreatic cancer	0.000318	0.000561	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—JAG2—pancreatic cancer	0.000316	0.000558	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000313	0.000554	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MEN1—pancreatic cancer	0.000311	0.00055	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SCT—pancreatic cancer	0.000301	0.000532	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HEY1—pancreatic cancer	0.000301	0.000532	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SHH—pancreatic cancer	0.000297	0.000525	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000295	0.000522	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SST—pancreatic cancer	0.000294	0.000519	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IAPP—pancreatic cancer	0.000293	0.000518	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.00029	0.000512	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—JAG1—pancreatic cancer	0.000288	0.000508	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCK—pancreatic cancer	0.000287	0.000508	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000286	0.000506	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTHLH—pancreatic cancer	0.000282	0.000498	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTCH1—pancreatic cancer	0.000282	0.000498	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GLP1R—pancreatic cancer	0.00028	0.000495	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CNR2—pancreatic cancer	0.00028	0.000495	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCL8—pancreatic cancer	0.00028	0.000494	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCKAR—pancreatic cancer	0.000275	0.000487	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CNR1—pancreatic cancer	0.000271	0.000479	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—JAG2—pancreatic cancer	0.000267	0.000472	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MEN1—pancreatic cancer	0.000263	0.000465	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000263	0.000465	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GCG—pancreatic cancer	0.000262	0.000463	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SST—pancreatic cancer	0.000258	0.000455	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000255	0.00045	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000254	0.000449	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—JAG1—pancreatic cancer	0.000252	0.000445	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SHH—pancreatic cancer	0.000251	0.000444	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000251	0.000443	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AGTR1—pancreatic cancer	0.00025	0.000441	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOTCH4—pancreatic cancer	0.00025	0.000441	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IAPP—pancreatic cancer	0.000248	0.000438	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—STK11—pancreatic cancer	0.000246	0.000435	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTHLH—pancreatic cancer	0.000238	0.000421	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTCH1—pancreatic cancer	0.000238	0.000421	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CNR1—pancreatic cancer	0.000238	0.00042	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000231	0.000409	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000231	0.000408	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GCG—pancreatic cancer	0.00023	0.000406	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000223	0.000395	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000222	0.000392	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AGTR1—pancreatic cancer	0.000219	0.000387	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SST—pancreatic cancer	0.000218	0.000385	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—STK11—pancreatic cancer	0.000216	0.000381	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SMAD4—pancreatic cancer	0.000216	0.000381	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000215	0.000379	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000213	0.000377	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—JAG1—pancreatic cancer	0.000213	0.000376	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000212	0.000375	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HES1—pancreatic cancer	0.000211	0.000372	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000203	0.000358	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000202	0.000356	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CNR1—pancreatic cancer	0.000201	0.000355	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000195	0.000344	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000195	0.000344	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GCG—pancreatic cancer	0.000194	0.000343	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000194	0.000342	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	0.000189	0.000334	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000189	0.000333	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000187	0.000331	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	0.000185	0.000327	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HES1—pancreatic cancer	0.000185	0.000326	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TERT—pancreatic cancer	0.000185	0.000326	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STK11—pancreatic cancer	0.000182	0.000322	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000177	0.000312	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	0.000176	0.000312	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	0.000176	0.000311	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOE—pancreatic cancer	0.000172	0.000304	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000171	0.000303	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	0.00017	0.0003	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KDR—pancreatic cancer	0.000169	0.000298	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000165	0.000291	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TERT—pancreatic cancer	0.000162	0.000286	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000161	0.000284	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	0.00016	0.000282	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000159	0.000281	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PRSS1—pancreatic cancer	0.000158	0.00028	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000158	0.000279	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HES1—pancreatic cancer	0.000156	0.000276	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000155	0.000275	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	0.000155	0.000275	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	0.000155	0.000273	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	0.000154	0.000273	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGF—pancreatic cancer	0.000154	0.000271	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOE—pancreatic cancer	0.000151	0.000267	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000149	0.000264	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KDR—pancreatic cancer	0.000148	0.000261	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000144	0.000254	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	0.000142	0.00025	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000141	0.000249	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000139	0.000246	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ARG2—pancreatic cancer	0.000137	0.000243	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TERT—pancreatic cancer	0.000137	0.000242	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000137	0.000241	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000136	0.000241	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	0.000136	0.000241	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000135	0.000239	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGF—pancreatic cancer	0.000135	0.000238	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	0.000134	0.000236	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	0.000131	0.000231	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	0.00013	0.00023	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOE—pancreatic cancer	0.000128	0.000225	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KDR—pancreatic cancer	0.000125	0.000221	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	0.000124	0.000219	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000123	0.000217	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TYMP—pancreatic cancer	0.00012	0.000212	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	0.00012	0.000212	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	0.000119	0.00021	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000119	0.00021	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000119	0.00021	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000118	0.000208	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	0.000117	0.000207	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000115	0.000204	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	0.000115	0.000203	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	0.000114	0.000202	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGF—pancreatic cancer	0.000114	0.000201	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	0.000114	0.000201	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	0.000111	0.000195	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	0.00011	0.000194	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000108	0.00019	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	0.000107	0.000188	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	0.000106	0.000187	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	0.000105	0.000185	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	0.000104	0.000185	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	0.000104	0.000183	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	0.000103	0.000182	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000101	0.000179	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	0.0001	0.000177	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	0.0001	0.000177	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.0001	0.000177	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	9.97e-05	0.000176	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	9.92e-05	0.000175	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	9.7e-05	0.000171	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GLP1R—pancreatic cancer	9.68e-05	0.000171	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	9.61e-05	0.00017	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SRC—pancreatic cancer	9.55e-05	0.000169	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—DPYD—pancreatic cancer	9.52e-05	0.000168	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	9.35e-05	0.000165	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	9.3e-05	0.000164	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	9.26e-05	0.000164	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	9.21e-05	0.000163	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	9.18e-05	0.000162	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	9.11e-05	0.000161	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	9.08e-05	0.00016	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	9.04e-05	0.00016	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	9.03e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	8.83e-05	0.000156	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	8.81e-05	0.000156	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MYC—pancreatic cancer	8.55e-05	0.000151	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	8.53e-05	0.000151	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	8.48e-05	0.00015	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	8.43e-05	0.000149	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SRC—pancreatic cancer	8.37e-05	0.000148	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	8.37e-05	0.000148	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	8.2e-05	0.000145	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	8.15e-05	0.000144	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	8.12e-05	0.000143	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	8.07e-05	0.000143	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	8.05e-05	0.000142	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	7.9e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	7.9e-05	0.00014	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	7.83e-05	0.000138	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	7.67e-05	0.000136	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	7.63e-05	0.000135	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MYC—pancreatic cancer	7.5e-05	0.000132	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	7.48e-05	0.000132	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	7.44e-05	0.000131	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	7.34e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	7.26e-05	0.000128	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SRC—pancreatic cancer	7.07e-05	0.000125	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TP53—pancreatic cancer	7.02e-05	0.000124	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CD44—pancreatic cancer	7e-05	0.000124	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	6.93e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	6.89e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	6.82e-05	0.000121	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	6.81e-05	0.00012	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	6.72e-05	0.000119	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GCG—pancreatic cancer	6.71e-05	0.000118	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	6.37e-05	0.000112	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MYC—pancreatic cancer	6.34e-05	0.000112	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	6.32e-05	0.000112	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—STK11—pancreatic cancer	6.31e-05	0.000111	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	6.2e-05	0.00011	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TP53—pancreatic cancer	6.16e-05	0.000109	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	5.93e-05	0.000105	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	5.89e-05	0.000104	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	5.86e-05	0.000103	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.43e-05	9.58e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	5.38e-05	9.51e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TP53—pancreatic cancer	5.21e-05	9.2e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	5.2e-05	9.19e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	4.98e-05	8.79e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOE—pancreatic cancer	4.41e-05	7.79e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	4.4e-05	7.77e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.98e-05	7.03e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.84e-05	6.79e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.5e-05	6.18e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.05e-05	5.39e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.02e-05	5.34e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.64e-05	4.66e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.86e-05	3.29e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.52e-05	2.68e-05	CbGpPWpGaD
